Filing Details

Accession Number:
0001181431-13-059543
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-11-18 19:43:10
Reporting Period:
2013-11-14
Filing Date:
2013-11-18
Accepted Time:
2013-11-18 19:43:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
878526 Natus Medical Inc BABY Electromedical & Electrotherapeutic Apparatus (3845) 770154833
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1217126 M William Moore C/O Natus Medical Incorporated
1501 Industrial Road
San Carlos CA 94070
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Per Share Disposition 2013-11-14 2,278 $22.05 52,614 No 4 S Indirect By Family Trust
Common Stock, $0.001 Par Value Per Share Disposition 2013-11-15 7,722 $22.00 44,892 No 4 S Indirect By Family Trust
Common Stock, $0.001 Par Value Per Share Acquisiton 2013-11-15 10,000 $10.03 54,892 No 4 M Indirect By Family Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Family Trust
No 4 S Indirect By Family Trust
No 4 M Indirect By Family Trust
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Nonqualified Stock Option Acquisiton 2013-11-15 10,000 $0.00 0 $10.03
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
10,000 2005-07-09 2015-06-09 No 4 M Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $0.001 Par Value Per Share 93,660 Direct
Common Stock, $0.001 Par Vale Per Share 4,150 Indirect By Spouse
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $22.00 to $22.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.